354 related articles for article (PubMed ID: 9710672)
1. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
Hooper DC
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S54-63. PubMed ID: 9710672
[TBL] [Abstract][Full Text] [Related]
2. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
3. Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.
Anderson VE; Osheroff N
Curr Pharm Des; 2001 Mar; 7(5):337-53. PubMed ID: 11254893
[TBL] [Abstract][Full Text] [Related]
4. DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica K; Zhao X
Microbiol Mol Biol Rev; 1997 Sep; 61(3):377-92. PubMed ID: 9293187
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of fluoroquinolone action.
Drlica K
Curr Opin Microbiol; 1999 Oct; 2(5):504-8. PubMed ID: 10508721
[TBL] [Abstract][Full Text] [Related]
6. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
Anderson VE; Zaniewski RP; Kaczmarek FS; Gootz TD; Osheroff N
Biochemistry; 2000 Mar; 39(10):2726-32. PubMed ID: 10704224
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of and resistance to quinolones.
Bearden DT; Danziger LH
Pharmacotherapy; 2001 Oct; 21(10 Pt 2):224S-232S. PubMed ID: 11642689
[TBL] [Abstract][Full Text] [Related]
8. Mode of action of the new quinolones: new data.
Hooper DC; Wolfson JS
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):223-31. PubMed ID: 1650698
[TBL] [Abstract][Full Text] [Related]
9. Overcoming target-mediated quinolone resistance in topoisomerase IV by introducing metal-ion-independent drug-enzyme interactions.
Aldred KJ; Schwanz HA; Li G; McPherson SA; Turnbough CL; Kerns RJ; Osheroff N
ACS Chem Biol; 2013 Dec; 8(12):2660-8. PubMed ID: 24047414
[TBL] [Abstract][Full Text] [Related]
10. DNA Topoisomerases as Targets for Antibacterial Agents.
Hiasa H
Methods Mol Biol; 2018; 1703():47-62. PubMed ID: 29177732
[TBL] [Abstract][Full Text] [Related]
11. Usual and unusual antibacterial effects of quinolones.
Furet YX; Pechère JC
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():7-15. PubMed ID: 2175306
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
13. The 4-quinolone antibiotics: past, present, and future.
Stein GE
Pharmacotherapy; 1988; 8(6):301-14. PubMed ID: 2851772
[TBL] [Abstract][Full Text] [Related]
14. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
15. Gyrase and Topoisomerase IV: Recycling Old Targets for New Antibacterials to Combat Fluoroquinolone Resistance.
Collins JA; Osheroff N
ACS Infect Dis; 2024 Apr; 10(4):1097-1115. PubMed ID: 38564341
[TBL] [Abstract][Full Text] [Related]
16. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.
Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H
Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
Hammonds TR; Foster SR; Maxwell A
J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis.
Onodera Y; Tanaka M; Sato K
J Antimicrob Chemother; 2001 Apr; 47(4):447-50. PubMed ID: 11266418
[TBL] [Abstract][Full Text] [Related]
19. DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones.
Saiki AY; Shen LL; Chen CM; Baranowski J; Lerner CG
Antimicrob Agents Chemother; 1999 Jul; 43(7):1574-7. PubMed ID: 10390205
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of action of quinolone drugs.
Palumbo M; Gatto B; Zagotto G; Palù G
Trends Microbiol; 1993 Sep; 1(6):232-5. PubMed ID: 8137121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
